Physician profile
Chris Arca
NPI 1275987216
$608.84
in general payments reported to CMS, 2019-2025
13 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.67 · 2023: $181 · 2024: $130 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $183.31 | 2024-2025 | |
| Cranial Technologies, INC | $69.62 | 2023-2025 | Doc Band |
| Livanova USA, INC. | $57.89 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Cumberland Pharmaceuticals, INC. | $56.19 | 2023 | Kristalose |
| Merck Sharp & Dohme LLC | $47.52 | 2023-2024 | Vaxneuvance, Rotateq, Vaxelis |
| Seqirus USA INC | $38.09 | 2021-2023 | Flucelvax Quadrivalent |
| Acadia Pharmaceuticals INC | $31.81 | 2025 | Daybue |
| Phadia US INC. | $28.31 | 2023 | Immunocap |
| Verrica Pharmaceuticals INC. | $26.23 | 2024 | Ycanth |
| Nestle Healthcare Nutrition INC. | $19.91 | 2023 | |
| Sobi, INC | $19.78 | 2024 | |
| Biomarin Pharmaceutical INC. | $15.62 | 2024 | Brineura |
| Glaxosmithkline, LLC. | $14.56 | 2024 | Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Arca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.